Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Resolution of Staphylococcus aureus biofilm infection using vaccination and antibiotic treatment.

Brady RA, O'May GA, Leid JG, Prior ML, Costerton JW, Shirtliff ME.

Infect Immun. 2011 Apr;79(4):1797-803. doi: 10.1128/IAI.00451-10. Epub 2011 Jan 10.

2.

Identification of Staphylococcus aureus proteins recognized by the antibody-mediated immune response to a biofilm infection.

Brady RA, Leid JG, Camper AK, Costerton JW, Shirtliff ME.

Infect Immun. 2006 Jun;74(6):3415-26.

3.

Impact of vancomycin on sarA-mediated biofilm formation: role in persistent endovascular infections due to methicillin-resistant Staphylococcus aureus.

Abdelhady W, Bayer AS, Seidl K, Moormeier DE, Bayles KW, Cheung A, Yeaman MR, Xiong YQ.

J Infect Dis. 2014 Apr 15;209(8):1231-40. doi: 10.1093/infdis/jiu007. Epub 2014 Jan 7.

4.
5.

Daptomycin is effective as antibiotic-lock therapy in a model of Staphylococcus aureus catheter-related infection.

Meije Y, Almirante B, Del Pozo JL, Martín MT, Fernández-Hidalgo N, Shan A, Basas J, Pahissa A, Gavaldà J.

J Infect. 2014 Jun;68(6):548-52. doi: 10.1016/j.jinf.2014.01.001. Epub 2014 Jan 8.

PMID:
24412247
6.

Novel rat model of methicillin-resistant Staphylococcus aureus-infected silicone breast implants: a study of biofilm pathogenesis.

Arad E, Navon-Venezia S, Gur E, Kuzmenko B, Glick R, Frenkiel-Krispin D, Kramer E, Carmeli Y, Barnea Y.

Plast Reconstr Surg. 2013 Feb;131(2):205-14. doi: 10.1097/PRS.0b013e3182778590.

PMID:
23076419
7.

Telavancin shows superior activity to vancomycin with multidrug-resistant Staphylococcus aureus in a range of in vitro biofilm models.

Smith K, Gemmell CG, Lang S.

Eur J Clin Microbiol Infect Dis. 2013 Oct;32(10):1327-32. doi: 10.1007/s10096-013-1883-z. Epub 2013 Apr 29.

PMID:
23624635
8.

A Diagnostic Serum Antibody Test for Patients With Staphylococcus aureus Osteomyelitis.

Nishitani K, Beck CA, Rosenberg AF, Kates SL, Schwarz EM, Daiss JL.

Clin Orthop Relat Res. 2015 Sep;473(9):2735-49. doi: 10.1007/s11999-015-4354-2. Epub 2015 May 27.

PMID:
26013151
9.

Human methicillin-sensitive Staphylococcus aureus biofilms: potential associations with antibiotic resistance persistence and surface polysaccharide antigens.

Babra C, Tiwari J, Costantino P, Sunagar R, Isloor S, Hegde N, Mukkur T.

J Basic Microbiol. 2014 Jul;54(7):721-8. doi: 10.1002/jobm.201200557. Epub 2013 May 17.

PMID:
23686411
10.

Linezolid limits burden of methicillin-resistant Staphylococcus aureus in biofilm of tracheal tubes.

Fernández-Barat L, Ferrer M, Sierra JM, Soy D, Guerrero L, Vila J, Li Bassi G, Cortadellas N, Martínez-Olondris P, Rigol M, Esperatti M, Luque N, Saucedo LM, Agustí C, Torres A.

Crit Care Med. 2012 Aug;40(8):2385-9. doi: 10.1097/CCM.0b013e31825332fc.

PMID:
22622402
11.

Efficacy of combined vancomycin and fosfomycin against methicillin-resistant Staphylococcus aureus in biofilms in vivo.

Shi J, Mao NF, Wang L, Zhang HB, Chen Q, Liu H, Tang X, Jin T, Zhu CT, Li FB, Sun LH, Xu XM, Xu YQ.

PLoS One. 2014 Dec 31;9(12):e113133. doi: 10.1371/journal.pone.0113133. eCollection 2014.

12.

Efficacy of telavancin in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis: studies with a rabbit model.

Yin LY, Calhoun JH, Thomas TS, Wirtz ED.

J Antimicrob Chemother. 2009 Feb;63(2):357-60. doi: 10.1093/jac/dkn490. Epub 2008 Dec 5.

13.

Protein antigens increase the protective efficacy of a capsule-based vaccine against Staphylococcus aureus in a rat model of osteomyelitis.

Lattar SM, Noto Llana M, Denoël P, Germain S, Buzzola FR, Lee JC, Sordelli DO.

Infect Immun. 2014 Jan;82(1):83-91. doi: 10.1128/IAI.01050-13. Epub 2013 Oct 14.

14.
15.

A review of telavancin activity in in vitro biofilms and animal models of biofilm-associated infections.

Chan C, Hardin TC, Smart JI.

Future Microbiol. 2015;10(8):1325-38. doi: 10.2217/fmb.15.53. Epub 2015 Jun 17.

16.

Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration.

Harro JM, Peters BM, O'May GA, Archer N, Kerns P, Prabhakara R, Shirtliff ME.

FEMS Immunol Med Microbiol. 2010 Aug;59(3):306-23. doi: 10.1111/j.1574-695X.2010.00708.x. Epub 2010 May 29. Review.

17.

A combined pharmacodynamic quantitative and qualitative model reveals the potent activity of daptomycin and delafloxacin against Staphylococcus aureus biofilms.

Bauer J, Siala W, Tulkens PM, Van Bambeke F.

Antimicrob Agents Chemother. 2013 Jun;57(6):2726-37. doi: 10.1128/AAC.00181-13. Epub 2013 Apr 9.

18.

Antibiotic susceptibility of ica-positive and ica-negative MRSA in different phases of biofilm growth.

Chopra S, Harjai K, Chhibber S.

J Antibiot (Tokyo). 2015 Jan;68(1):15-22. doi: 10.1038/ja.2014.96. Epub 2014 Jul 30.

PMID:
25074658
19.

Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin.

Smith K, Perez A, Ramage G, Gemmell CG, Lang S.

Int J Antimicrob Agents. 2009 Apr;33(4):374-8. doi: 10.1016/j.ijantimicag.2008.08.029. Epub 2008 Dec 19.

PMID:
19101124
20.

In vitro and in vivo antibiofilm activity of a coral associated actinomycete against drug resistant Staphylococcus aureus biofilms.

Bakkiyaraj D, Pandian SK.

Biofouling. 2010 Aug;26(6):711-7. doi: 10.1080/08927014.2010.511200.

PMID:
20706890
Items per page

Supplemental Content

Write to the Help Desk